Lyra Therapeutics, Inc.

8-K Terminated a material agreement Apr 17, 2026 8-K Terminated a material agreement Apr 10, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Delisting notice or listing-rule failure Mar 16, 2026 8-K Triggering event accelerating an obligation Feb 27, 2026 8-K Delisting notice or listing-rule failure Feb 6, 2026 8-K Exit or disposal costs; Director or officer change; Other events Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Other events Sep 4, 2025 8-K Delisting notice or listing-rule failure Aug 22, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 12, 2025 8-K Director or officer change Aug 1, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jun 27, 2025 8-K Other events Jun 23, 2025 8-K Other events Jun 9, 2025 8-K Amended charter or bylaws; Regulation FD disclosure; Other events Jun 2, 2025 8-K Shareholder vote results; Other events May 19, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Results of operations (earnings release) Mar 13, 2025 8-K Regulation FD disclosure Jan 10, 2025 8-K Director or officer change Dec 13, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 14, 2024 8-K Delisting notice or listing-rule failure Jul 23, 2024 8-K Amended charter or bylaws; Shareholder vote results Jun 18, 2024 8-K/A Exit or disposal costs Jun 7, 2024 8-K Exit or disposal costs; Director or officer change May 21, 2024 10-Q Quarter ended 2024-03-31 Apr 30, 2024 8-K Results of operations (earnings release) Apr 30, 2024 8-K Director or officer change Apr 19, 2024 10-K Fiscal year ended 2023-12-31 Mar 22, 2024 8-K Results of operations (earnings release) Mar 21, 2024 8-K Director or officer change Mar 1, 2024 8-K Regulation FD disclosure; Other events Jan 8, 2024